Results 161 to 170 of about 123,600 (352)

Cytogenetic Features of Elderly Turkish Myelodysplastic Syndrome Patients

open access: hybrid, 2016
Muzaffer Keklık   +8 more
openalex   +1 more source

Molecular-Based Score inspired on metabolic signature improves prognostic stratification for myelodysplastic syndrome [PDF]

open access: gold, 2021
Juan Luiz Coelho‐Silva   +9 more
openalex   +1 more source

Challenges of Dengue in Hematological Disease Patients: Descriptive Analysis From the DANGO Registry During the 2023–2024 Outbreak in Argentina

open access: yesTransplant Infectious Disease, EarlyView.
During the 2023–2024 Argentine dengue outbreak, 33 patients with hematological disease showed high complication rates, frequent hospitalization (64%), severe thrombocytopenia (90%), and 6% dengue‐attributable mortality. Transfusion‐associated cases were documented.
Gustavo Adolfo Méndez   +16 more
wiley   +1 more source

Deferasirox-induced urticarial vasculitis in a patient with myelodysplastic syndrome [PDF]

open access: gold, 2017
Asude Kara Polat   +3 more
openalex   +1 more source

Aberrantly elevated suprabasin in the bone marrow as a candidate biomarker of advanced disease state in myelodysplastic syndromes [PDF]

open access: gold, 2020
Miroslav Přibyl   +12 more
openalex   +1 more source

Clinical application of a modified platelet desialylation test for mechanistic characterization of platelet transfusion refractoriness

open access: yesTransfusion, EarlyView.
Abstract Background Platelet transfusion refractoriness (PTR) is a major challenge in transfusion medicine and may result from both immune and non‐immune mechanisms. Although alloantibodies are well‐established contributors, Fc‐independent pathways such as platelet desialylation have emerged as alternative mechanisms of clearance.
Karen Ziza   +11 more
wiley   +1 more source

Case Report: A novel WRN mutation in Werner syndrome patient with diabetic foot disease and myelodysplastic syndrome [PDF]

open access: gold, 2022
Huifang Peng   +7 more
openalex   +1 more source

Home - About - Disclaimer - Privacy